Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 2 |
Pissara et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4HEI6
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016310 | phosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0006810 | transport | 3 | 2 |
GO:0006897 | endocytosis | 5 | 2 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 2 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018209 | peptidyl-serine modification | 6 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004672 | protein kinase activity | 3 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016301 | kinase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.329 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 341 | 343 | PF00675 | 0.364 |
CLV_NRD_NRD_1 | 461 | 463 | PF00675 | 0.515 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.375 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.329 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.337 |
CLV_PCSK_KEX2_1 | 341 | 343 | PF00082 | 0.491 |
CLV_PCSK_KEX2_1 | 447 | 449 | PF00082 | 0.505 |
CLV_PCSK_KEX2_1 | 461 | 463 | PF00082 | 0.585 |
CLV_PCSK_PC1ET2_1 | 447 | 449 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.460 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.354 |
CLV_PCSK_SKI1_1 | 242 | 246 | PF00082 | 0.314 |
CLV_PCSK_SKI1_1 | 295 | 299 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 317 | 321 | PF00082 | 0.247 |
CLV_PCSK_SKI1_1 | 327 | 331 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 341 | 345 | PF00082 | 0.374 |
CLV_PCSK_SKI1_1 | 506 | 510 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.477 |
DEG_APCC_DBOX_1 | 169 | 177 | PF00400 | 0.294 |
DEG_APCC_DBOX_1 | 263 | 271 | PF00400 | 0.275 |
DEG_APCC_DBOX_1 | 501 | 509 | PF00400 | 0.489 |
DOC_CKS1_1 | 304 | 309 | PF01111 | 0.386 |
DOC_CYCLIN_RxL_1 | 18 | 25 | PF00134 | 0.288 |
DOC_CYCLIN_RxL_1 | 321 | 332 | PF00134 | 0.351 |
DOC_CYCLIN_RxL_1 | 501 | 511 | PF00134 | 0.489 |
DOC_CYCLIN_yCln2_LP_2 | 375 | 381 | PF00134 | 0.542 |
DOC_MAPK_gen_1 | 210 | 218 | PF00069 | 0.330 |
DOC_MAPK_gen_1 | 231 | 238 | PF00069 | 0.264 |
DOC_MAPK_MEF2A_6 | 350 | 357 | PF00069 | 0.348 |
DOC_MAPK_NFAT4_5 | 350 | 358 | PF00069 | 0.356 |
DOC_PP1_RVXF_1 | 223 | 229 | PF00149 | 0.260 |
DOC_PP1_RVXF_1 | 325 | 332 | PF00149 | 0.367 |
DOC_PP2B_LxvP_1 | 353 | 356 | PF13499 | 0.522 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.477 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 392 | 396 | PF00917 | 0.519 |
DOC_USP7_MATH_1 | 471 | 475 | PF00917 | 0.584 |
DOC_USP7_UBL2_3 | 313 | 317 | PF12436 | 0.363 |
DOC_USP7_UBL2_3 | 51 | 55 | PF12436 | 0.374 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.375 |
LIG_14-3-3_CanoR_1 | 169 | 174 | PF00244 | 0.321 |
LIG_14-3-3_CanoR_1 | 327 | 332 | PF00244 | 0.347 |
LIG_14-3-3_CanoR_1 | 350 | 356 | PF00244 | 0.434 |
LIG_14-3-3_CanoR_1 | 370 | 376 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 396 | 401 | PF00244 | 0.576 |
LIG_14-3-3_CanoR_1 | 409 | 417 | PF00244 | 0.593 |
LIG_AP2alpha_1 | 33 | 37 | PF02296 | 0.397 |
LIG_APCC_ABBAyCdc20_2 | 193 | 199 | PF00400 | 0.314 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.552 |
LIG_BRCT_BRCA1_1 | 268 | 272 | PF00533 | 0.294 |
LIG_BRCT_BRCA1_1 | 427 | 431 | PF00533 | 0.454 |
LIG_BRCT_BRCA1_1 | 494 | 498 | PF00533 | 0.578 |
LIG_deltaCOP1_diTrp_1 | 439 | 445 | PF00928 | 0.430 |
LIG_FHA_1 | 294 | 300 | PF00498 | 0.332 |
LIG_FHA_2 | 304 | 310 | PF00498 | 0.351 |
LIG_FHA_2 | 425 | 431 | PF00498 | 0.523 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.494 |
LIG_LIR_Gen_1 | 145 | 155 | PF02991 | 0.421 |
LIG_LIR_Gen_1 | 247 | 255 | PF02991 | 0.324 |
LIG_LIR_Gen_1 | 269 | 278 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 336 | 344 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 439 | 450 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 224 | 230 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 247 | 253 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 269 | 275 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 318 | 322 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 32 | 36 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 336 | 340 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 439 | 445 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.431 |
LIG_LYPXL_yS_3 | 59 | 62 | PF13949 | 0.353 |
LIG_NRBOX | 83 | 89 | PF00104 | 0.372 |
LIG_PDZ_Class_2 | 511 | 516 | PF00595 | 0.489 |
LIG_Pex14_2 | 33 | 37 | PF04695 | 0.417 |
LIG_PTB_Apo_2 | 27 | 34 | PF02174 | 0.415 |
LIG_SH2_CRK | 250 | 254 | PF00017 | 0.324 |
LIG_SH2_CRK | 337 | 341 | PF00017 | 0.482 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.394 |
LIG_SH2_GRB2like | 337 | 340 | PF00017 | 0.295 |
LIG_SH2_STAP1 | 438 | 442 | PF00017 | 0.430 |
LIG_SH2_STAP1 | 64 | 68 | PF00017 | 0.374 |
LIG_SH2_STAT3 | 40 | 43 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.260 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.314 |
LIG_SH2_STAT5 | 276 | 279 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 322 | 325 | PF00017 | 0.361 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.398 |
LIG_SH3_3 | 355 | 361 | PF00018 | 0.419 |
LIG_SH3_3 | 370 | 376 | PF00018 | 0.559 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.437 |
LIG_SH3_3 | 417 | 423 | PF00018 | 0.507 |
LIG_SUMO_SIM_anti_2 | 306 | 312 | PF11976 | 0.371 |
LIG_SUMO_SIM_par_1 | 175 | 181 | PF11976 | 0.425 |
LIG_SUMO_SIM_par_1 | 377 | 382 | PF11976 | 0.458 |
LIG_SUMO_SIM_par_1 | 393 | 402 | PF11976 | 0.625 |
LIG_SUMO_SIM_par_1 | 422 | 430 | PF11976 | 0.461 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.314 |
MOD_CK1_1 | 399 | 405 | PF00069 | 0.576 |
MOD_CK1_1 | 408 | 414 | PF00069 | 0.473 |
MOD_CK1_1 | 453 | 459 | PF00069 | 0.498 |
MOD_CK1_1 | 467 | 473 | PF00069 | 0.524 |
MOD_CK1_1 | 474 | 480 | PF00069 | 0.703 |
MOD_CK1_1 | 490 | 496 | PF00069 | 0.520 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.332 |
MOD_CK2_1 | 303 | 309 | PF00069 | 0.341 |
MOD_CK2_1 | 388 | 394 | PF00069 | 0.466 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.549 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.440 |
MOD_GlcNHglycan | 361 | 364 | PF01048 | 0.564 |
MOD_GlcNHglycan | 365 | 368 | PF01048 | 0.556 |
MOD_GlcNHglycan | 381 | 384 | PF01048 | 0.511 |
MOD_GlcNHglycan | 390 | 393 | PF01048 | 0.440 |
MOD_GlcNHglycan | 401 | 404 | PF01048 | 0.463 |
MOD_GlcNHglycan | 469 | 472 | PF01048 | 0.567 |
MOD_GlcNHglycan | 473 | 476 | PF01048 | 0.682 |
MOD_GlcNHglycan | 510 | 513 | PF01048 | 0.677 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.443 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.518 |
MOD_GSK3_1 | 299 | 306 | PF00069 | 0.367 |
MOD_GSK3_1 | 359 | 366 | PF00069 | 0.494 |
MOD_GSK3_1 | 384 | 391 | PF00069 | 0.565 |
MOD_GSK3_1 | 392 | 399 | PF00069 | 0.512 |
MOD_GSK3_1 | 401 | 408 | PF00069 | 0.466 |
MOD_GSK3_1 | 453 | 460 | PF00069 | 0.563 |
MOD_GSK3_1 | 467 | 474 | PF00069 | 0.542 |
MOD_GSK3_1 | 488 | 495 | PF00069 | 0.581 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.452 |
MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.419 |
MOD_N-GLC_1 | 363 | 368 | PF02516 | 0.492 |
MOD_N-GLC_1 | 92 | 97 | PF02516 | 0.499 |
MOD_N-GLC_2 | 165 | 167 | PF02516 | 0.260 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.377 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.314 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.167 |
MOD_NEK2_1 | 329 | 334 | PF00069 | 0.422 |
MOD_NEK2_1 | 351 | 356 | PF00069 | 0.459 |
MOD_NEK2_1 | 379 | 384 | PF00069 | 0.496 |
MOD_NEK2_1 | 450 | 455 | PF00069 | 0.545 |
MOD_NEK2_1 | 508 | 513 | PF00069 | 0.523 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.399 |
MOD_NEK2_2 | 96 | 101 | PF00069 | 0.480 |
MOD_PIKK_1 | 329 | 335 | PF00454 | 0.352 |
MOD_PIKK_1 | 408 | 414 | PF00454 | 0.563 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.310 |
MOD_PIKK_1 | 464 | 470 | PF00454 | 0.566 |
MOD_PIKK_1 | 488 | 494 | PF00454 | 0.561 |
MOD_PK_1 | 249 | 255 | PF00069 | 0.324 |
MOD_PK_1 | 396 | 402 | PF00069 | 0.577 |
MOD_PKA_1 | 169 | 175 | PF00069 | 0.314 |
MOD_PKA_1 | 231 | 237 | PF00069 | 0.294 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.314 |
MOD_PKA_2 | 408 | 414 | PF00069 | 0.611 |
MOD_Plk_1 | 80 | 86 | PF00069 | 0.422 |
MOD_Plk_2-3 | 482 | 488 | PF00069 | 0.496 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.421 |
MOD_Plk_4 | 396 | 402 | PF00069 | 0.641 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.379 |
MOD_SUMO_for_1 | 200 | 203 | PF00179 | 0.260 |
MOD_SUMO_for_1 | 50 | 53 | PF00179 | 0.371 |
MOD_SUMO_rev_2 | 63 | 68 | PF00179 | 0.326 |
TRG_DiLeu_BaEn_2 | 267 | 273 | PF01217 | 0.260 |
TRG_DiLeu_BaLyEn_6 | 393 | 398 | PF01217 | 0.570 |
TRG_DiLeu_BaLyEn_6 | 420 | 425 | PF01217 | 0.470 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 250 | 253 | PF00928 | 0.324 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.383 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.424 |
TRG_ER_diArg_1 | 169 | 171 | PF00400 | 0.330 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.307 |
TRG_ER_diArg_1 | 340 | 342 | PF00400 | 0.358 |
TRG_ER_diArg_1 | 513 | 516 | PF00400 | 0.531 |
TRG_NLS_MonoExtN_4 | 54 | 59 | PF00514 | 0.418 |
TRG_Pf-PMV_PEXEL_1 | 341 | 346 | PF00026 | 0.406 |
TRG_Pf-PMV_PEXEL_1 | 506 | 510 | PF00026 | 0.487 |
TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.388 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2H3 | Leptomonas seymouri | 31% | 100% |
A0A0N1IKB0 | Leptomonas seymouri | 31% | 91% |
A0A1X0NZS9 | Trypanosomatidae | 44% | 100% |
A0A3Q8IJ66 | Leishmania donovani | 45% | 100% |
A0A3S7WNZ6 | Leishmania donovani | 30% | 94% |
A0A3S7WZA2 | Leishmania donovani | 79% | 100% |
A0A422NL83 | Trypanosoma rangeli | 51% | 100% |
A4H436 | Leishmania braziliensis | 32% | 100% |
A4HFV0 | Leishmania braziliensis | 31% | 92% |
A4HIT6 | Leishmania braziliensis | 43% | 100% |
A4HMD1 | Leishmania braziliensis | 45% | 100% |
A4HSC0 | Leishmania infantum | 30% | 94% |
A4I1K4 | Leishmania infantum | 79% | 100% |
A4IAZ8 | Leishmania infantum | 45% | 100% |
C9ZK43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
C9ZM31 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 75% |
E9AKA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AXN8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 99% |
E9B1C3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
E9B5Y1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 100% |
O96999 | Leishmania major | 31% | 94% |
P42158 | Arabidopsis thaliana | 39% | 100% |
Q4Q6U1 | Leishmania major | 40% | 100% |
Q4Q9T3 | Leishmania major | 77% | 97% |
Q5R4V3 | Pongo abelii | 37% | 100% |
Q62763 | Rattus norvegicus | 38% | 100% |
Q6K9N1 | Oryza sativa subsp. japonica | 44% | 100% |
Q6NRT0 | Xenopus laevis | 41% | 100% |
Q86Y07 | Homo sapiens | 23% | 100% |
Q8WQ99 | Caenorhabditis elegans | 40% | 100% |
Q9NHE1 | Leishmania major | 45% | 100% |
Q9Y6M4 | Homo sapiens | 38% | 100% |